Published in J Med Vet Mycol on January 31, 1996
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol (2008) 1.51
Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol (2003) 1.29
Activities of available and investigational antifungal agents against rhodotorula species. J Clin Microbiol (2005) 1.26
Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16
Catheter-related sepsis due to Rhodotorula glutinis. J Clin Microbiol (2003) 0.82
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84
Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis (2001) 4.94
Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med (1980) 4.45
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med (1980) 3.03
Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 2.77
The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA (1998) 2.69
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med (1987) 2.64
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med (1981) 2.56
Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol (1978) 2.44
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med (1992) 2.25
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. Am J Med (1989) 2.20
Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med (1988) 2.17
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 2.15
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis (1995) 2.11
Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med (1987) 2.04
Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis (1986) 2.04
Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med (1997) 2.00
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet (1986) 1.96
Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. Infect Immun (1998) 1.76
Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis (1999) 1.75
Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population. J Clin Microbiol (1979) 1.71
Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.59
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med (1993) 1.46
Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis (1995) 1.43
Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice. Antimicrob Agents Chemother (1986) 1.42
Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infect Immun (1979) 1.41
Clinical research. Science (2000) 1.39
Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer. Infect Control (1984) 1.33
Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol (2009) 1.33
Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis (1990) 1.32
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med (1981) 1.28
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. Am J Med (1983) 1.26
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis (1983) 1.24
M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun (1987) 1.24
Nosocomial dermatitis and pruritus caused by pigeon mite infestation. Arch Intern Med (1987) 1.21
Rapid diagnosis of nocardiosis with an enzyme immunoassay. J Infect Dis (1987) 1.20
Antibody response in human nocardiosis: identification of two immunodominant culture-filtrate antigens derived from Nocardia asteroides. J Infect Dis (1985) 1.19
Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J Infect Dis (1987) 1.19
Survey of AIDS knowledge and behavior changes among Massachusetts adults. Prev Med (1989) 1.15
Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med (1984) 1.14
Risk factors for nosocomial pneumonia. Focus on prophylaxis. Med Clin North Am (2001) 1.12
Serogroup identification of meningococci by a modified antiserum agar method. J Clin Microbiol (1979) 1.12
Identification of a common immunodominant protein in culture filtrates of three Nocardia species and use in etiologic diagnosis of mycetoma. J Clin Microbiol (1987) 1.12
Cloning and nucleotide sequence of a specific DNA fragment from Paracoccidioides brasiliensis. J Clin Microbiol (1995) 1.11
Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes. Infect Immun (1982) 1.10
Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia? J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.10
Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs (2001) 1.10
Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug. J Antimicrob Chemother (1994) 1.08
Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis (1984) 1.08
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria. J Infect Dis (1977) 1.07
Capnocytophaga septicemia. N Engl J Med (1980) 1.07
Occupational hazards to hospital personnel. Ann Intern Med (1985) 1.07
Knowledge about HIV and behavioral risks of foreign-born Boston public school students. Am J Public Health (1991) 1.07
A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination. Am J Epidemiol (1984) 1.06
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) (1990) 1.05
Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature. Cancer (1985) 1.04
The Boston AIDS Survival Score (BASS): a multidimensional AIDS severity instrument. Am J Public Health (1997) 1.00
Use of paper-absorbed fingerstick blood samples for studies of antibody to human immunodeficiency virus type 1 in intravenous drug users. J Infect Dis (1990) 1.00
What's the price of a research subject? N Engl J Med (1999) 0.99
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making (1998) 0.99
Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro. J Leukoc Biol (1984) 0.98
Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol (2001) 0.97
Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry. Antimicrob Agents Chemother (1979) 0.96
Bacillus licheniformis sepsis. JAMA (1977) 0.95
Susceptibility of Blastomyces dermatitidis strains to products of oxidative metabolism. Infect Immun (1983) 0.95
Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am Rev Respir Dis (1983) 0.95
Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun (1985) 0.94
Contaminated condensate in mechanical ventilator circuits. A risk factor for nosocomial pneumonia? Am Rev Respir Dis (1984) 0.93
Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils. J Antimicrob Chemother (1989) 0.92
Familial multiple endocrine adenomatosis. Multiple endocrine neoplasia, type I. Arch Intern Med (1972) 0.92
Changes in insurance status and access to care for persons with AIDS in the Boston Health Study. Am J Public Health (1994) 0.92
Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical aspects. J Infect Dis (1986) 0.90
New rapid assay for nafcillin in serum by spectrofluorometry. Antimicrob Agents Chemother (1979) 0.90
Short report: use of the polymerase chain reaction to detect Paracoccidioides brasiliensis in murine paracoccidioidomycosis. Am J Trop Med Hyg (1998) 0.89
Contamination of mechanical ventilators with tubing changes every 24 or 48 hours. N Engl J Med (1982) 0.89
Ketoconazole treatment of coccidioidal meningitis. Ann N Y Acad Sci (1988) 0.89
Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement. Infect Immun (1983) 0.88
Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: implications for public health and obstetric practice. Am J Obstet Gynecol (1992) 0.87
Fungal meningitis. Infect Dis Clin North Am (1990) 0.87
Mycobacterium gordonae: a possible opportunistic respiratory tract pathogen in patients with advanced human immunodeficiency virus, type 1 infection. Chest (1991) 0.86
Nocardia in naturally acquired and experimental infections in animals. J Hyg (Lond) (1983) 0.86
Herpes zoster ophthalmicus and granulomatous angiitis. An ill-appreciated cause of stroke. J Am Geriatr Soc (1986) 0.86
Rifabutin prophylaxis and uveitis. N Engl J Med (1994) 0.86
The iron-hydrogen peroxide-iodide system is fungicidal: activity against the yeast phase of Blastomyces dermatitidis. J Leukoc Biol (1984) 0.86
Costs of medical care and out-of-pocket expenditures for persons with AIDS in the Boston Health Study. Inquiry (1995) 0.86
Fluconazole in transplant recipients: options and limitations. Transpl Infect Dis (2000) 0.85
Synthesis of heat-shock proteins in mycelia and yeast forms of Paracoccidioides brasiliensis. J Med Microbiol (1994) 0.85
In vitro activity of LY121019 against Candida species and Torulopsis glabrata. Eur J Clin Microbiol Infect Dis (1988) 0.85
Candida esophagitis. Adv Intern Med (1991) 0.85
Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine. Am J Med (1986) 0.84
Pneumonia in the critically ill hospitalized patient. Chest (1990) 0.84
Fungicidal activity of murine broncho-alveolar macrophages against Blastomyces dermatitidis. J Med Microbiol (1986) 0.84